Mild hyperphosphatemia and mortality in hemodialysis patients.
about
Recent advances in the management of hemodialysis patients: a focus on cardiovascular diseaseIs there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysisFGF-23 as a predictor of renal outcome in diabetic nephropathyMicrovolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy.Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysisInteraction of time-varying albumin and phosphorus on mortality in incident dialysis patients.Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patientsSerum Anion Gap Predicts All-Cause Mortality in Patients with Advanced Chronic Kidney Disease: A Retrospective Analysis of a Randomized Controlled Study.Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patientsPublic health approach to addressing hyperphosphatemia among dialysis patients.The adequacy of phosphorus binder prescriptions among American hemodialysis patients.Mineral metabolism disturbances in patients with chronic kidney disease.Mineral metabolic abnormalities and mortality in dialysis patients.Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients.Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients.Management of phosphorus load in CKD patients.Aerobic exercise increases phosphate removal during hemodialysis: a controlled trial.A Japanese approach for CKD-MBDSerum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients.Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.Survival-Related Autophagic Activity Versus Procalcific Death in Cultured Aortic Valve Interstitial Cells Treated With Critical Normophosphatemic-Like Phosphate Concentrations.Effect of stage-based education provided by dedicated dietitians on hyperphosphataemic haemodialysis patients: results from the Nutrition Education for Management of Osteodystrophy randomised controlled trial.Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling.Chronic hemodialysis patients without marked elevation of intact parathyroid hormone are also good candidates for early intervention with cinacalcet.Frequent hemodialysis: history of the modality and assessment of outcomes.Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis.Compliance with mineral metabolism targets in haemodialysis patients: moving backwards?Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation.Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms
P2860
Q26849298-227F8DE7-697B-4196-8A8B-975839167B90Q27011288-A317055F-9810-44D1-8A7E-1A065155967BQ34639537-B1BB1D28-3CEB-4F24-8985-2289645270BEQ34857667-CAE61A1A-C0F8-4D2E-B948-E98C3306CCF9Q35351243-3B48EAE0-7AA9-4300-A93D-C997B02C7DA7Q35985866-0F46AD2E-FA5F-47B2-A8DC-B7BE91527ACAQ36001212-BBFB06C4-8C10-4C49-9645-2382EA3CF651Q36036427-28D8EAA5-E9C0-4342-AB30-A90661B02B25Q36063658-863D691D-1EC9-4AFA-9B0F-0B0ECB489C74Q36667038-550B9DD0-BC5E-4F64-85BD-B3545281092EQ36716948-B5E5640E-D3E3-44C1-A6F3-E4DDA047E035Q36884206-E302B92E-BB92-422A-8E71-2648AF649AA6Q36994038-7C9AC9E2-B14A-4D49-BA00-302C12BCDE99Q37075732-41E121E0-57F9-461C-B920-58B734FE6C43Q38828902-ECD74CD8-8878-493C-B41C-CA4A6A0BFB05Q38925728-767D5774-A631-424A-963D-A2FE687AAC92Q39023147-E458E1A7-247E-49E6-A3F7-442EE430244AQ39269791-28C5693B-BFC2-4B58-82D7-E32DE9F80295Q42727652-2ED89DBF-CB25-4A51-BE08-5002AD297633Q43405909-B11F515F-B817-4E55-ADE9-A3968242F80EQ43427754-C53FBC5E-00D2-4BFD-904B-AFE9A7C46651Q50188358-FC8255FF-088B-461E-B148-F3742C038471Q50786312-C1DF6233-6D50-476E-AD8D-3597D2DBE555Q50910952-2CF192B4-F1DF-47F5-9949-B4DB914E6010Q51207887-6BDE05DE-B2F1-4203-A77B-4804C29FDA2DQ53365078-615567E3-99AC-48D5-AE12-4ED50207E84BQ53775627-F2B49CB3-5011-4B47-9627-B494910985B1Q53780644-C1763C11-B091-4A40-B4D2-161A2D66BBE5Q55496554-E52D2A80-FD6E-4516-ACC4-FA98D0E98188Q58747343-2DA9B9E8-D9A5-41BC-8C7C-F4992806C70A
P2860
Mild hyperphosphatemia and mortality in hemodialysis patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Mild hyperphosphatemia and mortality in hemodialysis patients.
@en
Mild hyperphosphatemia and mortality in hemodialysis patients.
@nl
type
label
Mild hyperphosphatemia and mortality in hemodialysis patients.
@en
Mild hyperphosphatemia and mortality in hemodialysis patients.
@nl
prefLabel
Mild hyperphosphatemia and mortality in hemodialysis patients.
@en
Mild hyperphosphatemia and mortality in hemodialysis patients.
@nl
P2093
P1476
Mild hyperphosphatemia and mortality in hemodialysis patients.
@en
P2093
Alberto Rodriguez-Benot
Alejandro Martin-Malo
M Antonia Alvarez-Lara
Mariano Rodriguez
Pedro Aljama
P356
10.1053/J.AJKD.2005.04.006
P577
2005-07-01T00:00:00Z